Christian Hartmann Selected Research

Oligodendroglioma

1/2021	Rare germline variants in the E-cadherin gene CDH1 are associated with the risk of brain tumors of neuroepithelial and epithelial origin.
11/2016	Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study.
8/2012	No prognostic value of IDH1 mutations in a series of 100 WHO grade II astrocytomas.
7/2011	Molecular markers in low-grade gliomas: predictive or prognostic?
6/2011	Immunohistochemical analysis of 1844 human epithelial and haematopoietic tumours and sarcomas for IDH1R132H mutation.
2/2011	Mutation-specific IDH1 antibody differentiates oligodendrogliomas and oligoastrocytomas from other brain tumors with oligodendroglioma-like morphology.
3/2010	PCR- and restriction endonuclease-based detection of IDH1 mutations.
10/2009	Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.
12/2007	Combined 1p/19q loss in oligodendroglial tumors: predictive or prognostic biomarker?
8/2006	Identification of novel oligodendroglioma-associated candidate tumor suppressor genes in 1p36 and 19q13 using microarray-based expression profiling.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christian Hartmann Research Topics

Disease

63	Neoplasms (Cancer) 07/2022 - 07/2002
35	Glioma (Gliomas) 01/2021 - 04/2002
26	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 05/2005
19	Astrocytoma (Pilocytic Astrocytoma) 11/2018 - 08/2006
11	Oligodendroglioma 01/2021 - 10/2004
9	Brain Neoplasms (Brain Tumor) 01/2021 - 12/2008
7	Meningioma (Meningiomas) 07/2022 - 02/2003
7	Neurofibrosarcoma (MPNST) 01/2016 - 02/2004
4	Infections 11/2018 - 09/2003
3	Neurilemmoma (Schwannoma) 07/2022 - 04/2014
3	Stroke (Strokes) 10/2021 - 01/2021
3	Carcinogenesis 01/2021 - 04/2004
3	Sarcoma (Soft Tissue Sarcoma) 01/2016 - 06/2011
3	Disease Progression 07/2012 - 10/2005
2	Ischemic Stroke 01/2021 - 01/2021
2	Demyelinating Diseases (Demyelinating Disease) 01/2019 - 01/2018
2	Carcinoma (Carcinomatosis) 12/2017 - 06/2011
2	Leiomyosarcoma 09/2014 - 04/2014
2	Thymoma (Thymic Carcinoma) 12/2013 - 04/2011
2	Necrosis 06/2012 - 04/2009
2	Neurofibroma 08/2007 - 03/2006
2	Corneal Injuries 09/2003 - 09/2003
1	Pain (Aches) 07/2022
1	Hearing Loss (Hearing Impairment) 07/2022
1	Neurofibromatosis 2 (Neurofibromatosis Type II) 07/2022
1	COVID-19 01/2022
1	Nervous System Diseases (Neurological Disorders) 01/2022
1	Peripheral Nerve Injuries 01/2022
1	Neurologic Manifestations (Neurological Manifestations) 01/2022
1	Foreign-Body Reaction 01/2022
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2022
1	Turcot syndrome 01/2021
1	Hypothermia 01/2021
1	Paraganglioma (Paragangliomas) 12/2020
1	Medulloblastoma 01/2020
1	Adrenoleukodystrophy (Adrenoleukodystrophy, X-Linked) 01/2019
1	Metachromatic Leukodystrophy (Sulfatide Lipidosis) 01/2019

Drug/Important Bio-Agent (IBA)

20	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2004
17	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 04/2018 - 12/2008
13	DNA (Deoxyribonucleic Acid)IBA 07/2022 - 10/2005
10	Temozolomide (Temodar)FDA LinkGeneric 01/2021 - 10/2005
10	Biomarkers (Surrogate Marker)IBA 02/2020 - 12/2007
6	Codon (Codons)IBA 06/2016 - 12/2008
6	Messenger RNA (mRNA)IBA 10/2015 - 10/2007
5	RNA (Ribonucleic Acid)IBA 01/2021 - 08/2006
5	Biological ProductsIBA 03/2015 - 10/2005
5	ParaffinIBA 05/2013 - 11/2009
4	Tretinoin (Retinoic Acid)FDA LinkGeneric 10/2015 - 04/2011
3	AntibodiesIBA 06/2016 - 02/2004
3	Neurofibromin 1 (Neurofibromin)IBA 01/2016 - 07/2004
3	O(6)-Methylguanine-DNA MethyltransferaseIBA 01/2012 - 12/2009
3	Formaldehyde (Formol)FDA Link 01/2012 - 11/2009
2	Bevacizumab (Avastin)FDA Link 07/2022 - 01/2021
2	Reticulin (Reticular Fiber)IBA 01/2022 - 04/2014
2	Complement System Proteins (Complement)IBA 10/2021 - 12/2010
2	Keratins (Keratin)IBA 12/2020 - 01/2014
2	Pharmaceutical PreparationsIBA 02/2020 - 04/2009
2	CollagenIBA 10/2019 - 01/2011
2	SteroidsIBA 01/2018 - 05/2007
2	Phosphotransferases (Kinase)IBA 08/2017 - 01/2012
2	MethyltransferasesIBA 11/2016 - 01/2011
2	Monoclonal AntibodiesIBA 08/2016 - 01/2010
2	Hormones (Hormone)IBA 10/2015 - 05/2007
2	Telomerase (Telomerase Reverse Transcriptase)IBA 12/2013 - 05/2007
2	Carrier Proteins (Binding Protein)IBA 10/2012 - 04/2011
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2012 - 05/2007
2	N 30IBA 07/2011 - 12/2007
2	Matrix Metalloproteinase 13IBA 08/2007 - 02/2004
2	Complementary DNA (cDNA)IBA 08/2006 - 07/2004
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 04/2005 - 07/2002
2	janus greenIBA 09/2003 - 09/2003
1	Cell Adhesion MoleculesIBA 01/2022
1	FibrinIBA 01/2022
1	Silk FDA Link 01/2022
1	Fenofibrate (CiL)FDA LinkGeneric 01/2022
1	CateninsIBA 01/2021
1	Cadherins (E-Cadherin)IBA 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	Sertraline (Zoloft)FDA LinkGeneric 01/2021
1	Keratin-18 (Keratin 18)IBA 12/2020
1	Oligodendrocyte Transcription Factor 2IBA 01/2020
1	Methotrexate (Mexate)FDA LinkGeneric 01/2020
1	NestinIBA 01/2020
1	Glycoproteins (Glycoprotein)IBA 01/2019
1	LipidsIBA 01/2019
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2019
1	Polytetrafluoroethylene (Teflon)FDA Link 11/2018
1	Oxidized CelluloseIBA 11/2018

Therapy/Procedure

30	Therapeutics 07/2022 - 07/2002
15	Radiotherapy 01/2020 - 04/2007
14	Drug Therapy (Chemotherapy) 01/2021 - 01/2005
6	Chemoradiotherapy 02/2020 - 12/2009
2	Re-Irradiation 12/2014 - 04/2010
2	Ligation 01/2012 - 01/2011
2	Penetrating Keratoplasty 02/2006 - 07/2002
1	Critical Care (Surgical Intensive Care) 01/2022
1	Length of Stay 01/2021
1	Craniospinal Irradiation 01/2020
1	Craniotomy 11/2018
1	Sutures (Suture) 11/2018